Proteomic analysis of a rat model of depression

References

• Naismith SL, Hickie IB, Turner K et al. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J. Clin. Exp. Neuropsychol.25(6), 866–877 (2003).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Une T. Animal models of psychiatric disorder and their validity – from the perspective of behavioral pharmacology. Nippon Yakurigaku Zasshi120(3), 173–180 (2002).
   PubMedGoogle Scholar
• Sergeyev V, Fetissov S, Mathé AA et al. Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology (Berl.)178(2–3), 115–124 (2005).
   PubMedGoogle Scholar
• Willner P, Owell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology93, 358–364 (1987).
   PubMed Web of Science ®Google Scholar
• Overstreet DH. The Flinders sensitive line rats: a genetic animal model of depression. Neurosci. Biobehav. Rev.17, 51–68 (1993).
   PubMed Web of Science ®Google Scholar
• Mathé AA, Jimenez PA, Theodorsson E, Stenfors C, Neuropeptide Y. Neurokinin A and neurotensin in brain regions of fawn hooded “depressed,” Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli. Prog. Neuropsychopharmacol. Biol. Psychiatry22, 529–546 (1998).
   PubMedGoogle Scholar
• Ladd CO, Owens MJ, Nemeroff CB, Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology137, 1212–1218 (1996).
   PubMed Web of Science ®Google Scholar
• Lumia AR, Teicher MH, Salchli F et al. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res.587(2), 181–185 (1992).
   PubMed Web of Science ®Google Scholar
• Malkesman O, Braw Y, Zagoory-Sharon O et al. Reward and anxiety in genetic animal models of childhood depression. Behav. Brain Res.164(1), 1–10 (2005).
   PubMedGoogle Scholar
• Wann BP, Bah TM, Boucher M et al. Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J. Psychiatry Neurosci.32(1), 11–16 (2007).
   PubMedGoogle Scholar
• No authors listed. Best of the 2003 AUA Annual Meeting. Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003, Chicago, IL. Rev. Urol.5(3), 156–181 (2003).
   PubMedGoogle Scholar
• Nestler EJ, Barrot M, DiLeone RJ et al. Neurobiology of depression. Neuron34, 13–25 (2002).
   PubMed Web of Science ®Google Scholar
• Moreau JL, Jenck F, Martin JR. Simulation of a core symptom of human depression in rats. Curr. Top. Pharmacol.4, 37–50 (1998).
   Google Scholar
• Janowsky DS, Overstreet DH, Nurberger JI. Is cholinergic sensitivity a genetic marker for the affective disorders? Am. J. Med. Genet.54, 335–344 (1994).
   PubMed Web of Science ®Google Scholar
• Overstreet DH, Friedman E, Mathé AA et al. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev.29(4–5), 739–759 (2005).
   PubMed Web of Science ®Google Scholar
• Tejani-Butt S, Kluczynski J, Paré WP. Strain-dependent modification of behavior following antidepressant treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry.27(1), 7–14 (2003).
   PubMedGoogle Scholar
• Pennington K, Cotter D, Dunn MJ. The role of proteomics in investigating psychiatric disorders. Br. J. Psychiatry187, 4–6 (2005).
   PubMedGoogle Scholar
• De Haro L, Panda S. Systems biology of circadian rhythms: an outlook. J. Biol. Rhythms21(6), 507–518 (2006).
   PubMedGoogle Scholar
• O’Farrell PH. High resolution two dimensional electrophoresis of proteins. J. Biol. Chem.250, 4007–4021 (1975).
   PubMed Web of Science ®Google Scholar
• Shekouh AR,Thompson CC, Prime W et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics3, 1988–2001 (2003).
   PubMed Web of Science ®Google Scholar
• Tribl F, Marcus K, Bringmann G et al. Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. J. Neural Transm.113, 1041–1054 (2006).
   PubMed Web of Science ®Google Scholar
• Tammen H, Peck A, Budde P et al. Peptidomics analysis of human blood specimens for biomarker discovery. Expert Rev. Mol. Diagn.7(5), 605–613 (2007).
   PubMed Web of Science ®Google Scholar
• Maier CS, Deinzer ML, Protein conformations, interactions, and H/D exchange. Methods Enzymol.402, 312–360 (2005).
   PubMedGoogle Scholar
• Vestergaarda M, Kermanb K, Kimc DK. Detection of Alzheimer’s tau protein using localised surface plasmon resonance-based immunochip. Talanta74(4), 1038–1042 (2008).
   PubMedGoogle Scholar
• Campbell S, Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci.29(6), 417–426 (2004).
   PubMed Web of Science ®Google Scholar
• Duman RS, Malberg J, Nakagawa S, D’Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry48(8), 732–739 (2001).
   Google Scholar
• Khawaja X, Xu J, Liang JJ, Barrett JE. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res.75(4), 451–460 (2004).
   PubMedGoogle Scholar
• Mu J, Xie P, Yang ZS et al. Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model. Neurosci. Lett.416(3), 252–256 (2007).
   PubMedGoogle Scholar
• Bisgaard CF, Jayatissa MN, Enghild JJ et al. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J. Mol. Neurosci.32(2), 132–144 (2007).
   PubMedGoogle Scholar
• Lerer B, Macciardi F, Segman RH et al. Variability of 5-HT2C receptor Cys23Ser polymorphism among European populations and vulnerability to affective disorder. Mol. Psychiatry6, 579–585 (2001).
   PubMed Web of Science ®Google Scholar
• Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry49(5), 391–404 (2001).
   PubMed Web of Science ®Google Scholar
• Boyle MP, Brewer JA, Funatsu M et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl Acad. Sci. USA102(2), 473–478 (2005).
   PubMed Web of Science ®Google Scholar
• Hanash S. Disease proteomics. Nature422(6928), 226–232 (2003).
   PubMed Web of Science ®Google Scholar
• Brunner J, Bronisch T, Uhr M et al. Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. Eur. Arch. Psychiatry Clin. Neurosci.255(6), 438–440 (2005).
   PubMed Web of Science ®Google Scholar
• Soo-Quee Koh D, Choon-Huat Koh G. The use of salivary biomarkers in occupational and environmental medicine. Occup. Environ. Med.64(3), 202–210 (2007).
   PubMedGoogle Scholar
• Zobel AW, Nickel T, Sonntag A et al. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J. Psychiatr. Res.35(2), 83–94 (2001).
   PubMed Web of Science ®Google Scholar
• Perel P, Roberts I, Sena E et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. Br. Med. J.334(7586), 197 (2007).
   PubMed Web of Science ®Google Scholar
• Palanza P. Animal models of anxiety and depression: how are females different? Neurosci. Biobehav. Rev.25(3), 219–233 (2001).
   PubMed Web of Science ®Google Scholar
• No authors listed. Proceedings of the 1st Symposium for Brain Bank, 22 October 2006, Fukushima, Japan. Psychiatry Clin. Neurosci.61, S19–S23 (2007).
   Web of Science ®Google Scholar
• Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov.4(9), 775–790 (2005).
   PubMed Web of Science ®Google Scholar
• Murgatroyd C, Wigger A, Frank E et al. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J. Neurosci.24(35), 7762–7770 (2004).
   PubMed Web of Science ®Google Scholar